Author

Sarah Goldie

Commonwealth Scientific and Industrial Research Organisation

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Aditya V. VashiiD· 1 shared Alexander J. McAuleyiD· 1 shared Anupama KumariD· 1 shared Bang M. TraniD· 1 shared Carl M. J. KirkpatrickiD· 1 shared Carmel O’BrieniD· 1 shared Christopher A. MacRaildiD· 1 shared Darren J. CreekiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Aditya V. VashiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 Infection

Nathan Gödde, Carmel O’Brien, Elizabeth Vincan, Aditya V. Vashi, Stephanie Olliff, Bang M. Tran, Shafagh A. Waters, Sarah Goldie, Petrus Jansen van Vuren, Shane Riddell, Matthew P. Bruce, Vinti Agarwal, Eugene Athan, Kim R. Blasdell, Simran Chahal, , Seshadri S. Vasan

The paper validates repurposed drugs against SARS-CoV-2 using stem cell-derived cardiomyocyte and nasal epithelium models, confirming fluvoxamine's antiviral efficacy in combination with other drugs.

bioRxiv · May 22, 2024 · PreprintMicrobiology